Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2007

May 3, 2007

34519_dirs_2007-05-03_fecb4287-ff96-43cf-8e77-cfe4abfe1e60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-05-01

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-05-01 Common Stock, par value $0.10 per share P 100 $5.51 Acquired 394367 Direct
2007-05-01 Common Stock, par value $0.10 per share P 100 $5.53 Acquired 394467 Direct
2007-05-01 Common Stock, par value $0.10 per share P 105 $5.41 Acquired 394572 Direct
2007-05-01 Common Stock, par value $0.10 per share P 361 $5.55 Acquired 394933 Direct
2007-05-02 Common Stock, par value $0.10 per share P 300 $5.57 Acquired 395233 Direct
2007-05-02 Common Stock, par value $0.10 per share P 17 $5.61 Acquired 395250 Direct
2007-05-02 Common Stock, par value $0.10 per share P 203 $5.62 Acquired 395453 Direct
2007-05-02 Common Stock, par value $0.10 per share P 110 $5.63 Acquired 395563 Direct
2007-05-02 Common Stock, par value $0.10 per share P 400 $5.57 Acquired 395963 Direct

Footnotes

F1: These shares of common stock were acquired by Arterio, Inc. a corporation owned solely by Mr. Rothschild.

F2: This figure includes 197,650 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.